Unlike other food allergieswhich might disappear kids grow

July 8, 2010 by Johnson Anders
Filed under: Food 

Unlike other food allergieswhich might disappear as kids grow up or respond to doctor-supervised challenges allowing a child to build up a tolerance to the food — a peanut allergy usually lasts a lifetime, Shreffler and colleagues note in the Journal of Allergy and Clinical Immunology. And the severity of reactions may vary widely one accidental exposure may lead to a minor rash, the next could be fatal.

The research team, from Berlins University Hospital Charite and Mount Sinai Medical Center in New York, wanted to know if a therapy could be developed that was safe to take by mouth and would reduce the threat of accidental peanut ingestion in peanut-allergic kids.

These patients were carefully selected to have an extremely low probability of growing out of their peanut allergy, said Shreffler, who now practices at Bostons General Hospital.

In the study, the first of its kind, tiny amounts of crushed peanuts were given by mouth to build up tolerance to peanut proteins. To limit the danger of a fatal reaction, the 23 children enrolled in the study were admitted to the hospital for the first week of therapy.

It took an average of 7 months of increasing doses for the kids to work up tolerance to one kernels worth of crushed peanut or 500 milligrams, more than is usually eaten in an accidental ingestion, the investigators say. After they reached 500 mg and were able to consume it daily without side effects for 8 weeks, they took two weeks off and then faced a new peanut food challenge.

Before this time, however, more than a third of the kids 35 percent dropped out of the study, a rate quite high compared to other studies, the investigators note. Allergic reactions ranging from upset stomach to wheezing were common in all the children. Four, or 17 percent, dropped out because of a bad allergic reaction, a higher adverse reaction rate than some previous work. One patient quit during the hospital phase because of anxiety. Two, including the youngest participant, who couldnt stomach the taste of the peanut/applesauce concoction, were dropped because they wouldnt follow the trial rules.

Fourteen children made it to the end of the study. At the final food challenge, all but two of them were able to tolerate 1 gram of peanut compared to .19 gram at the beginning of the study, leading the investigators to conclude that some patients might benefit from this approach known as oral immunotherapy.

The glass is half full, Shreffler said. The therapy was able to increase tolerance levels in many more than would have had any change on their own, he said while urging caution.

Whether the protection lasts longer than two weeks is not answered yet.

Theres evidence there may have been a permanent shift, but we havent proven that yet. Weve only taken the first step, Shreffler said.

The Food and Drug Administration does not regulate therapies such as this and Shreffler urges patients to be wary of anyone offering it.

Theres nothing regulatory to prevent Johnny allergist from starting to give crushed up peanuts to patients in the office, he said.

If a pill is developed, the FDA would become involved.

Thats the best hope. It could be in a pill form or it could be a well defined protocol, Shreffler said, but a good understanding of whats safe and who would benefit is at least five years away.

Clinical trials are underway testing other therapies too, he said, but in the meantime, total avoidance of peanuts and keeping an EPI pen on hand for an emergency injection in case of accidental ingestion, are the only sure ways to protect against a fatal reaction.

According to U.S. government figures, peanuts and tree nut allergies are the leading causes of fatal and near fatal food-allergic reactions.

SOURCE link.reuters.com/nyx36m Journal of Allergy and Clinical Immunology, July 2010 source

Comments

Tell me what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

You must be logged in to post a comment.